Medicine
fromFortune
18 hours ago'We'll save the world from cancer': Inside Pfizer CEO's $23 billion postCOVID bet on oncology | Fortune
Pfizer is investing $23 billion to pivot into oncology, allocating over 40% of R&D to cancer to offset falling COVID revenue and looming patent losses.